Terazosin hydrochloride

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68788-9815
  • Package NDC 68788-9815-1
  • Package NDC 68788-9815-3
  • Package NDC 68788-9815-6
  • Package NDC 68788-9815-9
  • Application number ANDA075317
  • SPL ID 22a5c8ce-fac9-4cca-ad67-a7dff1c9203e
  • SPL set ID 9d8fd052-b478-447e-a884-74fcd21275bb
  • UNII D32S14F082
  • RxCUI 313215
  • RxCUI 313217
  • RxCUI 313219

What the source publishes

Labeler
Preferred Pharmaceuticals, Inc
Active ingredients
Terazosin hydrochloride
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68788-9815_22a5c8ce-fac9-4cca-ad67-a7dff1c9203e
{
  "name": "Terazosin hydrochloride",
  "splId": "22a5c8ce-fac9-4cca-ad67-a7dff1c9203e",
  "labels": [
    {
      "setId": "9d8fd052-b478-447e-a884-74fcd21275bb",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9d8fd052-b478-447e-a884-74fcd21275bb",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9d8fd052-b478-447e-a884-74fcd21275bb"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Preferred Pharmaceuticals, Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 CAPSULE in 1 BOTTLE (68788-9815-1)",
      "package_ndc": "68788-9815-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20120405"
    },
    {
      "sample": false,
      "description": "30 CAPSULE in 1 BOTTLE (68788-9815-3)",
      "package_ndc": "68788-9815-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20120405"
    },
    {
      "sample": false,
      "description": "60 CAPSULE in 1 BOTTLE (68788-9815-6)",
      "package_ndc": "68788-9815-6",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20120405"
    },
    {
      "sample": false,
      "description": "90 CAPSULE in 1 BOTTLE (68788-9815-9)",
      "package_ndc": "68788-9815-9",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20120405"
    }
  ],
  "productId": "68788-9815_22a5c8ce-fac9-4cca-ad67-a7dff1c9203e",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "68788-9815",
  "deaSchedule": null,
  "genericName": "Terazosin hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TERAZOSIN HYDROCHLORIDE",
      "strength": "5 mg/1"
    }
  ],
  "applicationNumber": "ANDA075317",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20120405",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "D32S14F082"
    ],
    "rxcui": [
      "313215",
      "313217",
      "313219"
    ],
    "spl_set_id": [
      "9d8fd052-b478-447e-a884-74fcd21275bb"
    ],
    "manufacturer_name": [
      "Preferred Pharmaceuticals, Inc"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68788-9815_22a5c8ce-fac9-4cca-ad67-a7dff1c9203e"